Customer publications


  1. T. E. Assafa, S. Nandi, D. Śmiłowicz, L. Galazzo, M. Teucher, C. Elsner, S. Pütz, S. Bleicken, A. Y. Robin, D. Westphal, I. Uson, R. Stoll, P. E. Czabotar, N. Metzler-Nolte, E. Bordignon. Biophysical Characterization of Pro-apoptotic BimBH3 Peptides Reveals an Unexpected Capacity for Self-Association

    Structure, vol. 29, 2021, pp. 114-124.e3

  2. H. Baudhuin, P. J. Van Bockstal, T. De Beer, I. Vaneycken, J. Bridoux, G. Raes, V. Caveliers, M. Keyaerts, N. Devoogdt, T. Lahoutte, C. Xavier. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for ⁶⁸Ga-labeling

    Eur J Pharm Biopharm, vol. 166, 2021, pp. 194-204

  3. I. J. G. Burvenich, Y. W. Goh, N. Guo, H. K. Gan, A. Rigopoulos, D. Cao, Z. Liu, U. Ackermann, C. W. Wichmann, A. F. McDonald, N. Huynh, G. J. O\'Keefe, S. J. Gong, F. E. Scott, L. Li, W. Geng, A. Zutshi, Y. Lan, A. M. Scott. Radiolabelling and preclinical characterization of (89)Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 3075-3088

  4. Q. Cao, Q. Huang, Y. A. Wang, C. Li. Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with (64)Cu-labeled anti-CD11b and prevented by anti-CSF-1

    Theranostics, vol. 11, 2021, pp. 3527-3539

  5. A. Cavaliere, S. Sun, S. Lee, J. Bodner, Z. Li, Y. Huang, S. L. Moores, B. Marquez-Nostra. Development of ⁸⁹ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 383-394

  6. M. Chomet, M. Schreurs, M. J. Bolijn, M. Verlaan, W. Beaino, K. Brown, A. J. Poot, A. D. Windhorst, H. Gill, J. Marik, S. Williams, J. Cowell, G. Gasser, T. L. Mindt, Gams van Dongen, D. J. Vugts. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical ⁸⁹Zr-immuno-PET

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 694-707

  7. N. Dammes, M. Goldsmith, S. Ramishetti, J. L. J. Dearling, N. Veiga, A. B. Packard, D. Peer. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

    Nat Nanotechnol, vol. 16, 2021, pp. 1030-1038

  8. P. Diebolder, C. Mpoy, J. Scott, T. T. Huynh, R. Fields, D. Spitzer, N. Bandara, B. E. Rogers. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44

    J Nucl Med, vol. 62, 2021, pp. 137-143

  9. T. V. F. Esposito, H. Stütz, C. Rodríguez-Rodríguez, M. Bergamo, L. Charles, R. Geczy, C. Blackadar, J. P. Kutter, K. Saatchi, U. O. Häfeli. Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform

    ACS Biomater Sci Eng, vol. 7, 2021, pp. 2823-2834

  10. S. Fa, K. Adachi, Y. Nagata, K. Egami, K. Kato, T. Ogoshi. Pre-regulation of the planar chirality of pillar[5]arenes for preparing discrete chiral nanotubes

    Chem Sci, vol. 12, 2021, pp. 3483-3488

  11. C. A. Ferreira, L. Kang, C. Li, A. Kamkaew, K. E. Barrett, E. Aluicio-Sarduy, Y. Yang, J. W. Engle, D. Jiang, W. Cai. ImmunoPET of the differential expression of CD146 in breast cancer

    Am J Cancer Res, vol. 11, 2021, pp. 1586-1599

  12. Y. Funase, E. Nakamura, M. Kajita, Y. Saito, S. Oshikiri, M. Kitano, M. Tokura, A. Hino, T. Uehara. Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

    J Nucl Med, vol. 62, 2021, pp. 232-239

  13. A. Ghai, A. Zheleznyak, M. Mixdorf, J. O\'Neal, J. Ritchey, M. Rettig, J. DiPersio, M. Shokeen, S. Achilefu. Development of [⁸⁹Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 1302-1311

  14. A. Gonzalez-Junca, O. Reiners, L. D. Borrero-Garcia, D. Beckford-Vera, A. A. Lazar, W. Chou, S. Braunstein, H. VanBrocklin, B. L. Franc, M. H. Barcellos-Hoff. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors

    Int J Radiat Oncol Biol Phys, vol. 109, 2021, pp. 527-539

  15. L. Hao, N. Rohani, R. T. Zhao, E. M. Pulver, H. Mak, O. J. Kelada, H. Ko, H. E. Fleming, F. B. Gertler, S. N. Bhatia. Microenvironment-triggered multimodal precision diagnostics

    Nat Mater, vol. 20, 2021, pp. 1440-1448

  16. K. E. Henry, K. N. Mack, V. L. Nagle, M. Cornejo, A. O. Michel, I. L. Fox, M. Davydova, T. R. Dilling, N. Pillarsetty, J. S. Lewis. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

    Mol Cancer Ther, vol. 20, 2021, pp. 2026-2034

  17. K. E. Henry, T. M. Shaffer, K. N. Mack, J. Ring, A. Ogirala, S. Klein-Scory, C. Eilert-Micus, W. Schmiegel, T. Bracht, B. Sitek, M. Clyne, C. J. Reid, B. Sipos, J. S. Lewis, H. Kalthoff, J. Grimm. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer

    J Nucl Med, vol. 62, 2021, pp. 1384-1390

  18. Y. Huang, Z. Yang, F. Li, H. Zhao, C. Li, N. Yu, D. J. Hamilton, Z. Li. (64)Cu/(177)Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer

    J Med Chem, vol. 64, 2021, pp. 2705-2713

  19. C. Hutton, F. Heider, A. Blanco-Gomez, A. Banyard, A. Kononov, X. Zhang, S. Karim, V. Paulus-Hock, D. Watt, N. Steele, S. Kemp, E. K. J. Hogg, J. Kelly, R. F. Jackstadt, F. Lopes, M. Menotti, L. Chisholm, A. Lamarca, J. Valle, O. J. Sansom, C. Springer. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

    Cancer Cell, vol. 39, 2021, pp. 1227-1244.e20

  20. L. Kang, C. Li, Z. T. Rosenkrans, J. W. Engle, R. Wang, D. Jiang, X. Xu, W. Cai. Noninvasive Evaluation of CD20 Expression Using (64)Cu-Labeled F(ab')(2) Fragments of Obinutuzumab in Lymphoma

    J Nucl Med, vol. 62, 2021, pp. 372-378

  21. A. Koudrina, E. M. McConnell, J. A. Zurakowski, G. O. Cron, S. Chen, E. C. Tsai, M. C. DeRosa. Exploring the Unique Contrast Properties of Aptamer-Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi

    ACS Appl Mater Interfaces, vol. 13, 2021, pp. 9412-9424

  22. M. Krekorian, G. G. W. Sandker, K. R. G. Cortenbach, O. Tagit, N. K. van Riessen, R. Raavé, M. Srinivas, C. G. Figdor, S. Heskamp, Ehjg Aarntzen. Characterization of Intrinsically Radiolabeled Poly(lactic-co-glycolic acid) Nanoparticles for ex Vivo Autologous Cell Labeling and in Vivo Tracking

    Bioconjug Chem, vol. 32, 2021, pp. 1802-1811

  23. S. G. Lee, T. M. Kalidindi, H. Lou, K. Gangangari, B. Punzalan, A. Bitton, C. J. Lee, H. A. Vargas, S. Park, L. Bodei, M. G. Kharas, V. K. Singh, N. V. Kishore Pillarsetty, S. M. Larson. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs

    J Nucl Med, vol. 62, 2021, pp. 584-590

  24. M. Li, W. Wei, T. E. Barnhart, D. Jiang, T. Cao, K. Fan, J. W. Engle, J. Liu, W. Chen, W. Cai. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2737-2748

  25. A. A. Lo, J. Johnston, J. Li, D. Mandikian, M. Hristopoulos, R. Clark, D. Nickles, W. C. Liang, K. Hötzel, D. Dunlap, T. Pham, H. Cai, M. Ovacik, D. Bravo-Perez, E. Mai, D. Slaga, D. Ellerman, J. Ziai, K. Totpal, G. Lee, C. A. Boswell. Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer

    Mol Cancer Ther, vol. 20, 2021, pp. 716-725

  26. W. Lu, Y. Cong, D. Yang, D. Chen, G. Yang, Y. Wang, M. E. Van Dort, B. D. Ross, A. P. Mazar, B. B. Chu, H. Hong. Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography

    Mol Pharm, vol. 18, 2021, pp. 1690-1698

  27. T. Ma, H. Ryu, M. McGregor, B. Babcock, J. Neidleman, G. Xie, A. F. George, J. Frouard, V. Murray, G. Gill, E. Ghosn, E. W. Newell, S. A. Lee, N. R. Roan. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence

    J Immunol, vol. 207, 2021, pp. 1344-1356

  28. K. E. Martin, A. G. Cosby, E. Boros. Multiplex and In Vivo Optical Imaging of Discrete Luminescent Lanthanide Complexes Enabled by In Situ Cherenkov Radiation Mediated Energy Transfer

    J Am Chem Soc, vol. 143, 2021, pp. 9206-9214

  29. M. Minnix, V. Adhikarla, E. Caserta, E. Poku, R. Rockne, J. E. Shively, F. Pichiorri. Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

    J Nucl Med, vol. 62, 2021, pp. 795-801

  30. M. Minnix, L. Li, P. J. Yazaki, A. D. Miller, J. Chea, E. Poku, A. Liu, J. Y. C. Wong, R. C. Rockne, D. Colcher, J. E. Shively. TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using ²²⁵Ac-Labeled DOTAylated-huCC49 Antibody

    J Nucl Med, vol. 62, 2021, pp. 55-61

  31. V. L. Nagle, K. E. Henry, C. A. J. Hertz, M. S. Graham, C. Campos, L. F. Parada, N. Pandit-Taskar, A. Schietinger, I. K. Mellinghoff, J. S. Lewis. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [(64)Cu]Cu-NOTA-anti-CD8 PET

    Clin Cancer Res, vol. 27, 2021, pp. 1958-1966

  32. A. Nomani, G. Li, S. Yousefi, S. Wu, O. M. Malekshah, S. K. Nikkhoi, M. Pourfathi, R. Rizi, A. Hatefi. Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI

    J Control Release, vol. 337, 2021, pp. 132-143

  33. K. Ogawa, H. Echigo, K. Mishiro, S. Hirata, K. Washiyama, Y. Kitamura, K. Takahashi, K. Shiba, S. Kinuya. ⁶⁸Ga- and ²¹¹At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

    Mol Pharm, vol. 18, 2021, pp. 3553-3562

  34. P. M. R. Pereira, J. Norfleet, J. S. Lewis, F. E. Escorcia. Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

    J Nucl Med, vol. 62, 2021, pp. 366-371

  35. S. Prabhu, H. Deng, T. L. Cross, S. H. Shahoei, C. J. Konopka, N. Gonzalez Medina, C. C. Applegate, M. A. Wallig, L. W. Dobrucki, E. R. Nelson, A. M. Smith, K. S. Swanson. Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction

    Biomater Sci, vol. 9, 2021, pp. 506-518

  36. S. Qin, Y. Yu, H. Guan, Y. Yang, F. Sun, Y. Sun, J. Zhu, L. Xing, J. Yu, X. Sun. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with ⁶⁸Ga-labeled PD-L1 targeted nanobody

    Aging (Albany NY), vol. 13, 2021, pp. 13006-13022

  37. S. M. Rathmann, A. R. Genady, N. Janzen, V. Anipindi, S. Czorny, A. F. Rullo, S. Sadeghi, J. F. Valliant. A Versatile Platform for the Development of Radiolabeled Antibody-Recruiting Small Molecules

    Mol Pharm, vol. 18, 2021, pp. 2647-2656

  38. J. Ren, M. Xu, J. Chen, J. Ding, P. Wang, L. Huo, F. Li, Z. Liu. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody

    Theranostics, vol. 11, 2021, pp. 304-315

  39. M. R. Rudnick, I. M. Wahba, A. K. Leonberg-Yoo, D. Miskulin, H. I. Litt. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review

    Am J Kidney Dis, vol. 77, 2021, pp. 517-528

  40. B. H. Santich, S. M. Cheal, M. Ahmed, M. R. McDevitt, O. Ouerfelli, G. Yang, D. R. Veach, E. K. Fung, M. Patel, D. Burnes Vargas, A. A. Malik, H. F. Guo, P. B. Zanzonico, S. Monette, A. O. Michel, C. M. Rudin, S. M. Larson, N. K. Cheung. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

    Clin Cancer Res, vol. 27, 2021, pp. 532-541

  41. S. M. Sarrett, O. Keinänen, E. J. Dayts, G. Dewaele-Le Roi, C. Rodriguez, K. E. Carnazza, B. M. Zeglis. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy

    Nat Protoc, vol. 16, 2021, pp. 3348-3381

  42. I. Schulien, J. Kemming, V. Oberhardt, K. Wild, L. M. Seidel, S. Killmer, Sagar, F. Daul, M. Salvat Lago, A. Decker, H. Luxenburger, B. Binder, D. Bettinger, O. Sogukpinar, S. Rieg, M. Panning, D. Huzly, M. Schwemmle, G. Kochs, C. F. Waller, A. Nieters, D. Duerschmied, F. Emmerich, H. E. Mei, A. R. Schulz, S. Llewellyn-Lacey, D. A. Price, T. Boettler, B. Bengsch, R. Thimme, M. Hofmann, C. Neumann-Haefelin. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells

    Nat Med, vol. 27, 2021, pp. 78-85

  43. M. Schwabenland, H. Salié, J. Tanevski, S. Killmer, M. S. Lago, A. E. Schlaak, L. Mayer, J. Matschke, K. Püschel, A. Fitzek, B. Ondruschka, H. E. Mei, T. Boettler, C. Neumann-Haefelin, M. Hofmann, A. Breithaupt, N. Genc, C. Stadelmann, J. Saez-Rodriguez, P. Bronsert, K. P. Knobeloch. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions

    Immunity, vol. 54, 2021, pp. 1594-1610.e11

  44. T. Shaffer, A. Natarajan, S. S. Gambhir. PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes

    Clin Cancer Res, vol. 27, 2021, pp. 1932-1940

  45. F. Simonetta, I. S. Alam, J. K. Lohmeyer, B. Sahaf, Z. Good, W. Chen, Z. Xiao, T. Hirai, L. Scheller, P. Engels, O. Vermesh, E. Robinson, T. Haywood, A. Sathirachinda, J. Baker, M. B. Malipatlolla, L. M. Schultz, J. Y. Spiegel, J. T. Lee, D. B. Miklos, C. L. Mackall, S. S. Gambhir, R. S. Negrin. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET

    Clin Cancer Res, vol. 27, 2021, pp. 1058-1068

  46. S. L. Slania, D. Das, A. Lisok, Y. Du, Z. Jiang, R. C. Mease, S. P. Rowe, S. Nimmagadda, X. Yang, M. G. Pomper. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules

    J Med Chem, vol. 64, 2021, pp. 4059-4070

  47. D. Sonanini, C. M. Griessinger, B. F. Schörg, P. Knopf, K. Dittmann, M. Röcken, B. J. Pichler, M. Kneilling. Low-dose total body irradiation facilitates antitumoral Th1 immune responses

    Theranostics, vol. 11, 2021, pp. 7700-7714

  48. M. Tognetti, A. Gabor, M. Yang, V. Cappelletti, J. Windhager, O. M. Rueda, K. Charmpi, E. Esmaeilishirazifard, A. Bruna, N. de Souza, C. Caldas, A. Beyer, P. Picotti, J. Saez-Rodriguez, B. Bodenmiller. Deciphering the signaling network of breast cancer improves drug sensitivity prediction

    Cell Syst, vol. 12, 2021, pp. 401-418.e12

  49. C. Wang, Y. Chen, Y. N. Hou, Q. Liu, D. Zhang, H. Zhao, Y. Zhang, S. An, L. Li, J. Hou, G. Huang, J. Liu, Y. J. Zhao, W. Wei. ImmunoPET imaging of multiple myeloma with ⁶⁸Ga-NOTA-Nb1053

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2749-2760

  50. C. Wang, D. Cheng, N. Jalali Motlagh, E. G. Kuellenberg, G. R. Wojtkiewicz, S. P. Schmidt, R. Stocker, J. W. Chen. Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity

    J Med Chem, vol. 64, 2021, pp. 5874-5885

  51. S. Wang, J. Li, J. Hua, Y. Su, D. R. Beckford-Vera, W. Zhao, M. Jayaraman, T. L. Huynh, N. Zhao, Y. H. Wang, Y. Huang, F. Qin, S. Shen, D. Gioeli, R. Dreicer, R. Sriram, E. A. Egusa, J. Chou, F. Y. Feng, R. Aggarwal, M. J. Evans, Y. Seo, B. Liu, R. R. Flavell, J. He. Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

    Clin Cancer Res, vol. 27, 2021, pp. 1305-1315

  52. Y. Wang, H. Ni, S. Zhou, K. He, Y. Gao, W. Wu, M. Wu, Z. Wu, X. Qiu, Y. Zhou, B. Chen, D. Pan, C. Huang, M. Li, Y. Bian, M. Yang, L. Miao, J. Liu. Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

    Cancer Immunol Immunother, vol. 70, 2021, pp. 365-376

  53. N. R. Wong, J. Mohan, B. J. Kopecky, S. Guo, L. Du, J. Leid, G. Feng, I. Lokshina, O. Dmytrenko, H. Luehmann, G. Bajpai, L. Ewald, L. Bell, N. Patel, A. Bredemeyer, C. J. Weinheimer, J. M. Nigro, A. Kovacs, S. Morimoto, P. O. Bayguinov, M. R. Fisher, W. T. Stump, M. Greenberg, J. A. J. Fitzpatrick, S. Epelman, D. Kreisel, R. Sah, Y. Liu, H. Hu, K. J. Lavine. Resident cardiac macrophages mediate adaptive myocardial remodeling

    Immunity, vol. 54, 2021, pp. 2072-2088.e7

  54. J. Yang, C. Zhao, J. Lim, L. Zhao, R. L. Tourneau, Q. Zhang, D. Dobson, S. Joshi, J. Pang, X. Zhang, S. Pal, C. Andreou, H. Zhang, M. F. Kircher, H. Schmitthenner. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging

    Theranostics, vol. 11, 2021, pp. 2534-2549

  55. M. Zhang, J. Ye, Z. Xie, Y. Yan, J. Wang, X. Chen. Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands

    Bioconjug Chem, vol. 32, 2021, pp. 2108-2116

  56. Y. Zhang, X. Han, G. Nie. Responsive and activable nanomedicines for remodeling the tumor microenvironment

    Nat Protoc, vol. 16, 2021, pp. 405-430

  57. 2020

  58. A. K. Abu-Alfa. Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change

    Am J Kidney Dis, vol. 76, 2020, pp. 436-439

  59. M. Agnoletti, C. Rodríguez-Rodríguez, S. N. Kłodzińska, T. V. F. Esposito, K. Saatchi, H. Mørck Nielsen, U. O. Häfeli. Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

    ACS Nano, vol. 14, 2020, pp. 6693-6706

  60. I. S. Alam, F. Simonetta, L. Scheller, A. T. Mayer, S. Murty, O. Vermesh, T. W. Nobashi, J. K. Lohmeyer, T. Hirai, J. Baker, K. H. Lau, R. Negrin, S. S. Gambhir. Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease

    Cancer Res, vol. 80, 2020, pp. 4780-4790

  61. R. Balhorn, M. C. Balhorn. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers

    Oncotarget, vol. 11, 2020, pp. 3315-3349

  62. D. R. Beckford Vera, S. D. Fontaine, H. F. VanBrocklin, B. R. Hearn, R. Reid, G. W. Ashley, D. V. Santi, B. Bengsch, T. Ohtani, O. Khan, M. Setty, S. Manne, S. O'Brien, P. F. Gherardini, R. S. Herati, A. C. Huang, K. M. Chang, E. W. Newell, N. Bovenschen, D. Pe'er, S. M. Albelda, E. J. Wherry. PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89

    Mol Cancer Ther, vol. 19, 2020, pp. 673-679

  63. E. Berg, H. Gill, J. Marik, A. Ogasawara, S. Williams, G. van Dongen, D. Vugts, S. R. Cherry, A. F. Tarantal. Total-Body PET and Highly Stable Chelators Together Enable Meaningful (89)Zr-Antibody PET Studies up to 30 Days After Injection

    J Nucl Med, vol. 61, 2020, pp. 453-460

  64. C. C. Chen, D. Y. Chang, J. J. Li, H. W. Chan, J. T. Chen, C. H. Chang, R. S. Liu, C. A. Chang, C. L. Chen, H. E. Wang. Investigation of biodistribution and tissue penetration of PEGylated gold nanostars and their application for photothermal cancer treatment in tumor-bearing mice

    J Mater Chem B, vol. 8, 2020, pp. 65-77

  65. Z. Chen, M. Chen, Y. Cheng, T. Kowada, J. Xie, X. Zheng, J. Rao. Exploring the Condensation Reaction between Aromatic Nitriles and Amino Thiols To Optimize In Situ Nanoparticle Formation for the Imaging of Proteases and Glycosidases in Cells

    Angew Chem Int Ed Engl, vol. 59, 2020, pp. 3272-3279

  66. M. Chomet, M. Schreurs, M. Nguyen, B. Howng, R. Villanueva, M. Krimm, O. Vasiljeva, Gams van Dongen, D. J. Vugts. The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice

    Theranostics, vol. 10, 2020, pp. 5815-5828

  67. C. Christensen, L. K. Kristensen, M. Z. Alfsen, C. H. Nielsen, A. Kjaer. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1302-1313

  68. A. Corroyer-Dulmont, S. Valable, N. Falzone, A. M. Frelin-Labalme, O. Tietz, J. Toutain, M. S. Soto, D. Divoux, L. Chazalviel, E. A. Pérès, N. R. Sibson, K. A. Vallis, M. Bernaudin. VCAM-1 targeted alpha-particle therapy for early brain metastases

    Neuro Oncol, vol. 22, 2020, pp. 357-368

  69. W. Dawicki, K. J. H. Allen, R. Garg, E. M. Geoghegan, M. S. Berger, D. L. Ludwig, E. Dadachova. Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

    Oncotarget, vol. 11, 2020, pp. 3571-3581

  70. J. M. de Gooyer, F. M. K. Elekonawo, D. L. Bos, R. S. van der Post, A. Pèlegrin, B. Framery, F. Cailler, A. L. Vahrmeijer, J. H. W. de Wilt, M. Rijpkema. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using ¹¹¹In-Labeled SGM-101

    Clin Cancer Res, vol. 26, 2020, pp. 5934-5942

  71. D. N. Dorst, M. Rijpkema, M. Boss, B. Walgreen, M. M. A. Helsen, D. L. Bos, M. Brom, C. Klein, P. Laverman, P. M. van der Kraan, M. Gotthardt, M. I. Koenders, M. Buitinga. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis

    Rheumatology (Oxford), vol. 59, 2020, pp. 3952-3960

  72. L. Droctové, M. Lancien, V. L. Tran, M. Susset, B. Jego, F. Theodoro, P. Kessler, G. Mourier, P. Robin, S. S. Diarra, S. Palea, A. Flahault, A. Chorfa, M. Corbani, C. Llorens-Cortes, B. Mouillac, C. Mendre, A. Pruvost, D. Servent, C. Truillet, N. Gilles. A snake toxin as a theranostic agent for the type 2 vasopressin receptor

    Theranostics, vol. 10, 2020, pp. 11580-11594

  73. F. E. Escorcia, J. L. Houghton, D. Abdel-Atti, P. R. Pereira, A. Cho, N. T. Gutsche, K. E. Baidoo, J. S. Lewis. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors

    Theranostics, vol. 10, 2020, pp. 151-165

  74. X. Feng, Y. Wang, D. Lu, X. Xu, X. Zhou, H. Zhang, T. Zhang, H. Zhu, Z. Yang, F. Wang, N. Li, Z. Liu. Clinical Translation of a ⁶⁸Ga-Labeled Integrin α v β 6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer

    J Nucl Med, vol. 61, 2020, pp. 1461-1467

  75. T. M. Fenton, P. B. Jørgensen, K. Niss, S. J. S. Rubin, U. M. Mörbe, L. B. Riis, C. Da Silva, A. Plumb, J. Vandamme, H. L. Jakobsen, S. Brunak, A. Habtezion, O. H. Nielsen, B. Johansson-Lindbom, W. W. Agace. Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity

    Immunity, vol. 52, 2020, pp. 557-570.e6

  76. Gfds Fernandes, H. R. N. Salgado, J. L. D. Santos. A critical review of HPLC-based analytical methods for quantification of Linezolid

    Crit Rev Anal Chem, vol. 50, 2020, pp. 196-211

  77. E. Friebel, K. Kapolou, S. Unger, N. G. Núñez, S. Utz, E. J. Rushing, L. Regli, M. Weller, M. Greter, S. Tugues, M. C. Neidert, B. Becher. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes

    Cell, vol. 181, 2020, pp. 1626-1642.e20

  78. Jacm Goos, A. Cho, L. M. Carter, T. R. Dilling, M. Davydova, K. Mandleywala, S. Puttick, A. Gupta, W. S. Price, J. F. Quinn, M. R. Whittaker, J. S. Lewis, T. P. Davis. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect

    Theranostics, vol. 10, 2020, pp. 567-584

  79. J. R. Henriksen, T. B. Engel, A. L. Petersen, P. J. Kempen, F. Melander, P. Roos, R. I. Jølck, T. L. Andresen. Elucidating the anomalous membrane permeability of Ag(I), Cu(II), Zn(II) and Au(III) towards new nanoreactor strategies for synthesizing metal nanoparticles

    Nanoscale, vol. 12, 2020, pp. 22298-22306

  80. S. Hossaini Nasr, Z. Rashidijahanabad, S. Ramadan, N. Kauffman, N. Parameswaran, K. R. Zinn, C. Qian, R. Arora, D. Agnew, X. Huang. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles

    Nanoscale, vol. 12, 2020, pp. 9541-9556

  81. R. Houštecká, M. Hadzima, J. Fanfrlík, J. Brynda, L. Pallová, I. Hánová, H. Mertlíková-Kaiserová, M. Lepšík, M. Horn, M. Smrčina, P. Majer, M. Mareš. Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis

    J Med Chem, vol. 63, 2020, pp. 1576-1596

  82. C. W. Huang, Y. H. Chang, H. H. Lee, J. Y. Wu, J. X. Huang, Y. H. Chung, S. T. Hsu, L. P. Chow, K. C. Wei, F. T. Huang. Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma

    Faseb j, vol. 34, 2020, pp. 9678-9693

  83. A. Karimian, N. T. Ji, H. Song, G. Sgouros. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

    Cancer Res, vol. 80, 2020, pp. 868-876

  84. V. J. Kelly, S. T. Wu, V. Gottumukkala, R. Coelho, K. Palmer, S. Nair, T. Erick, R. Puri, O. Ilovich, P. Mukherjee. Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer

    Theranostics, vol. 10, 2020, pp. 6946-6958

  85. A. Kolstad, T. Illidge, N. Bolstad, S. Spetalen, U. Madsbu, C. Stokke, J. Blakkisrud, A. Løndalen, N. O\'Rourke, M. Beasley, W. Jurczak, U. M. Fagerli, M. Kaščák, M. Bayne, A. Obr, J. Dahle, L. Rojkjaer, V. Pascal, H. Holte. Phase 1/2a study of ¹⁷⁷Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

    Blood Adv, vol. 4, 2020, pp. 4091-4101

  86. K. E. Lindsay, D. Vanover, M. Thoresen, H. King, P. Xiao, P. Badial, M. Araínga, S. B. Park, P. M. Tiwari, H. E. Peck, E. L. Blanchard, J. M. Feugang, A. K. Olivier, C. Zurla, F. Villinger, A. R. Woolums, P. J. Santangelo. Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV

    Mol Ther, vol. 28, 2020, pp. 805-819

  87. D. Lobeek, M. Rijpkema, S. Y. A. Terry, J. D. M. Molkenboer-Kuenen, L. Joosten, E. A. J. van Genugten, A. C. H. van Engen-van Grunsven, Jham Kaanders, S. A. H. Pegge, O. C. Boerman, W. L. J. Weijs, M. A. W. Merkx, C. M. L. van Herpen, R. P. Takes, Ehjg Aarntzen, W. J. G. Oyen. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by ⁶⁸Ga-DOTA-E-[c(RGDfK)] 2 PET/CT

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2647-2655

  88. G. Lv, X. Sun, L. Qiu, Y. Sun, K. Li, Q. Liu, Q. Zhao, S. Qin, J. Lin. PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

    J Nucl Med, vol. 61, 2020, pp. 117-122

  89. N. Nair, S. Y. Chen, E. Lemmens, S. Chang, D. T. Le, E. M. Jaffee, A. Murphy, C. Whiting, T. Müller, D. G. Brockstedt. Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer

    Cancer Immunol Res, vol. 8, 2020, pp. 609-617

  90. T. D. T. Nguyen, R. Marasini, S. Rayamajhi, C. Aparicio, D. Biller, S. Aryal. Erythrocyte membrane concealed paramagnetic polymeric nanoparticle for contrast-enhanced magnetic resonance imaging

    Nanoscale, vol. 12, 2020, pp. 4137-4149

  91. Y. C. Ou, X. Wen, C. A. Johnson, D. Shae, O. D. Ayala, J. A. Webb, E. C. Lin, R. C. DeLapp, K. L. Boyd, A. Richmond, A. Mahadevan-Jansen, M. Rafat, J. T. Wilson, J. M. Balko, M. N. Tantawy, A. E. Vilgelm, R. Bardhan. Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies

    ACS Nano, vol. 14, 2020, pp. 651-663

  92. N. Pandit-Taskar, M. A. Postow, M. D. Hellmann, J. J. Harding, C. A. Barker, J. A. O'Donoghue, M. Ziolkowska, S. Ruan, S. K. Lyashchenko, F. Tsai, M. Farwell, T. C. Mitchell, R. Korn, W. Le, J. S. Lewis, W. A. Weber, D. Behera, I. Wilson, M. Gordon, A. M. Wu, J. D. Wolchok. First-in-Humans Imaging with (89)Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

    J Nucl Med, vol. 61, 2020, pp. 512-519

  93. E. Peplau, F. De Rose, S. Reder, M. Mittelhäuser, G. Scafetta, M. Schwaiger, W. A. Weber, A. Bartolazzi, A. Skerra, C. D\'Alessandria. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer

    Thyroid, vol. 30, 2020, pp. 1314-1326

  94. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, J. S. Lewis. Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors

    Clin Cancer Res, vol. 26, 2020, pp. 6215-6229

  95. A. Pichard, S. Marcatili, J. Karam, J. Constanzo, R. Ladjohounlou, A. Courteau, M. Jarlier, N. Bonnefoy, S. Patzke, V. Stenberg, P. Coopman, G. Cartron, I. Navarro-Teulon, A. Repetto-Llamazares, H. Heyerdahl, J. Dahle, M. Bardiès, J. P. Pouget. The therapeutic effectiveness of ¹⁷⁷Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

    Leukemia, vol. 34, 2020, pp. 1315-1328

  96. X. Qin, J. Sufi, P. Vlckova, P. Kyriakidou, S. E. Acton, V. S. W. Li, M. Nitz, C. J. Tape. Cell-type-specific signaling networks in heterocellular organoids

    Nat Methods, vol. 17, 2020, pp. 335-342

  97. I. Quelven, J. Monteil, M. Sage, A. Saidi, J. Mounier, A. Bayout, J. Garrier, M. Cogne, S. Durand-Panteix. ²¹²Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

    J Nucl Med, vol. 61, 2020, pp. 1058-1065

  98. S. Rayamajhi, R. Marasini, T. D. T. Nguyen, B. L. Plattner, D. Biller, S. Aryal. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

    Biomater Sci, vol. 8, 2020, pp. 2887-2904

  99. E. K. Sarbisheh, A. K. Salih, S. J. Raheem, J. S. Lewis, E. W. Price. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89

    Inorg Chem, vol. 59, 2020, pp. 11715-11727

  100. L. J. Savic, L. A. Doemel, I. T. Schobert, R. R. Montgomery, N. Joshi, J. J. Walsh, J. Santana, V. Pekurovsky, X. Zhang, M. Lin, L. Adam, A. Boustani, J. Duncan, L. Leng, R. J. Bucala, S. N. Goldberg, F. Hyder, D. Coman, J. Chapiro. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?

    Radiology, vol. 296, 2020, pp. 575-583

  101. L. J. Savic, I. T. Schobert, D. Peters, J. J. Walsh, F. M. Laage-Gaupp, C. A. Hamm, N. Tritz, L. A. Doemel, M. Lin, A. Sinusas, T. Schlachter, J. S. Duncan, F. Hyder, D. Coman, J. Chapiro. Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment

    Clin Cancer Res, vol. 26, 2020, pp. 428-438

  102. M. L. Senders, A. E. Meerwaldt, M. M. T. van Leent, B. L. Sanchez-Gaytan, J. C. van de Voort, Y. C. Toner, A. Maier, E. D. Klein, N. A. T. Sullivan, A. M. Sofias, H. Groenen, C. Faries, R. S. Oosterwijk, E. M. van Leeuwen, F. Fay, E. Chepurko, T. Reiner, R. Duivenvoorden, L. Zangi, R. M. Dijkhuizen, S. Hak. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging

    Nat Nanotechnol, vol. 15, 2020, pp. 398-405

  103. B. Shi, B. Zhang, Y. Zhang, Y. Gu, C. Zheng, J. Yan, W. Chen, F. Yan, J. Ye, H. Zhang. Multifunctional gap-enhanced Raman tags for preoperative and intraoperative cancer imaging

    Acta Biomater, vol. 104, 2020, pp. 210-220

  104. S. Slight-Webb, M. Smith, A. Bylinska, S. Macwana, C. Guthridge, R. Lu, J. T. Merrill, E. Chakravarty, C. Arriens, M. E. Munroe, H. T. Maecker, P. J. Utz, J. M. Guthridge, J. A. James. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype

    J Allergy Clin Immunol, vol. 146, 2020, pp. 1419-1433

  105. R. Tang, A. Zheleznyak, M. Mixdorf, A. Ghai, J. Prior, K. C. L. Black, M. Shokeen, N. Reed, P. Biswas, S. Achilefu. Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma

    ACS Nano, vol. 14, 2020, pp. 4255-4264

  106. L. Tortola, A. Jacobs, L. Pohlmeier, F. J. Obermair, F. Ampenberger, B. Bodenmiller, M. Kopf. High-Dimensional T Helper Cell Profiling Reveals a Broad Diversity of Stably Committed Effector States and Uncovers Interlineage Relationships

    Immunity, vol. 53, 2020, pp. 597-613.e6

  107. G. A. Ulaner, N. B. Sobol, J. A. O'Donoghue, A. S. Kirov, C. C. Riedl, R. Min, E. Smith, L. M. Carter, S. K. Lyashchenko, J. S. Lewis, C. O. Landgren. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging

    Radiology, vol. 295, 2020, pp. 606-615

  108. T. J. van Oostenbrugge, J. F. Langenhuijsen, E. Oosterwijk, O. C. Boerman, S. F. Jenniskens, W. J. G. Oyen, J. J. Fütterer, P. F. A. Mulders. Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1864-1870

  109. B. A. Vaughn, A. M. Brown, S. H. Ahn, J. R. Robinson, E. Boros. Is Less More? Influence of the Coordination Geometry of Copper(II) Picolinate Chelate Complexes on Metabolic Stability

    Inorg Chem, vol. 59, 2020, pp. 16095-16108

  110. Y. Wang, C. Zhang, J. Lai, Y. Zhao, D. Lu, R. Bao, X. Feng, T. Zhang, Z. Liu. Noninvasive PET tracking of post-transplant gut microbiota in living mice

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 991-1002

  111. W. Wei, D. Jiang, H. J. Lee, M. Li, C. J. Kutyreff, J. W. Engle, J. Liu, W. Cai. Development and characterization of CD54-targeted immunoPET imaging in solid tumors

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2765-2775

  112. A. W. Woodham, S. H. Zeigler, E. L. Zeyang, S. C. Kolifrath, R. W. Cheloha, M. Rashidian, R. J. Chaparro, R. D. Seidel, S. J. Garforth, J. L. Dearling, M. Mesyngier, P. K. Duddempudi, A. B. Packard, S. C. Almo, H. L. Ploegh. In vivo detection of antigen-specific CD8(+) T cells by immuno-positron emission tomography

    Nat Methods, vol. 17, 2020, pp. 1025-1032

  113. Z. Xiao, A. T. Mayer, T. W. Nobashi, S. S. Gambhir. ICOS Is an Indicator of T-cell-Mediated Response to Cancer Immunotherapy

    Cancer Res, vol. 80, 2020, pp. 3023-3032

  114. C. Xu, H. Hong, Y. Lee, K. S. Park, M. Sun, T. Wang, M. E. Aikins, Y. Xu, J. J. Moon. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets

    ACS Nano, vol. 14, 2020, pp. 13268-13278

  115. A. C. Yang, M. Y. Stevens, M. B. Chen, D. P. Lee, D. Stähli, D. Gate, K. Contrepois, W. Chen, T. Iram, L. Zhang, R. T. Vest, A. Chaney, B. Lehallier, N. Olsson, H. du Bois, R. Hsieh, H. C. Cropper, D. Berdnik, L. Li, E. Y. Wang, G. M. Traber. Physiological blood-brain transport is impaired with age by a shift in transcytosis

    Nature, vol. 583, 2020, pp. 425-430

  116. H. Zhu, T. L. Liu, C. H. Liu, J. Wang, H. Zhang, B. Dong, J. Shen, C. K. Zhao, Z. F. Li, Z. Cheng, Z. Yang. Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis

    Acta Pharmacol Sin, vol. 41, 2020, pp. 101-109

  117. 2019

  118. S. R. Banerjee, V. Kumar, A. Lisok, D. Plyku, Z. Nováková, M. Brummet, B. Wharram, C. Barinka, R. Hobbs, M. G. Pomper. Evaluation of ¹¹¹In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen

    J Nucl Med, vol. 60, 2019, pp. 400-406

  119. N. Beziere, K. Fuchs, A. Maurer, G. Reischl, J. Brück, K. Ghoreschi, B. Fehrenbacher, D. C. Berrio, K. Schenke-Layland, U. Kohlhofer, L. Quintanilla-Martinez, M. Gawaz, M. Kneilling, B. Pichler. Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix

    Theranostics, vol. 9, 2019, pp. 2868-2881

  120. D. V. Bower, J. K. Richter, H. von Tengg-Kobligk, J. T. Heverhagen, V. M. Runge. Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent

    Invest Radiol, vol. 54, 2019, pp. 453-463

  121. J. Boyken, T. Frenzel, J. Lohrke, G. Jost, G. Schütz, H. Pietsch. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats

    Invest Radiol, vol. 54, 2019, pp. 76-82

  122. C. Buchwalder, M. G. Jaraquemada-Peláez, J. Rousseau, H. Merkens, C. Rodríguez-Rodríguez, C. Orvig, F. Bénard, P. Schaffer, K. Saatchi, U. O. Häfeli. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular (89)Zr-THPN-Conjugates

    Inorg Chem, vol. 58, 2019, pp. 14667-14681

  123. L. Budzinski, A. R. Schulz, S. Baumgart, T. Burns, T. Rose, H. Hirseland, H. E. Mei. Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry

    J Immunol, vol. 202, 2019, pp. 3103-3112

  124. E. R. Butch, P. E. Mead, V. Amador Diaz, H. Tillman, E. Stewart, J. K. Mishra, J. Kim, A. Bahrami, J. L. J. Dearling, A. B. Packard, S. V. Stoddard, A. L. Vāvere, Y. Han, B. L. Shulkin, S. E. Snyder. Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma

    Cancer Res, vol. 79, 2019, pp. 3112-3124

  125. Q. Cao, Q. Huang, C. Mohan, C. Li. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using ⁶⁴Cu-αCD11b

    J Nucl Med, vol. 60, 2019, pp. 1317-1324

  126. D. Chen, Y. Zhou, D. Yang, M. Guan, M. Zhen, W. Lu, M. E. Van Dort, B. D. Ross, C. Wang, C. Shu, H. Hong. Positron Emission Tomography/Magnetic Resonance Imaging of Glioblastoma Using a Functionalized Gadofullerene Nanoparticle

    ACS Appl Mater Interfaces, vol. 11, 2019, pp. 21343-21352

  127. N. Dmochowska, W. Tieu, M. D. Keller, H. R. Wardill, C. Mavrangelos, M. A. Campaniello, P. Takhar, P. A. Hughes. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis

    J Nucl Med, vol. 60, 2019, pp. 858-863

  128. C. A. Dutertre, E. Becht, S. E. Irac, A. Khalilnezhad, V. Narang, S. Khalilnezhad, P. Y. Ng, L. L. van den Hoogen, J. Y. Leong, B. Lee, M. Chevrier, X. M. Zhang, P. J. A. Yong, G. Koh, J. Lum, S. W. Howland, E. Mok, J. Chen, A. Larbi, H. K. K. Tan, T. K. H. Lim, P. Karagianni, A. G. Tzioufas, B. Malleret, J. Brody, S. Albani, J. van Roon, T. Radstake, E. W. Newell, F. Ginhoux. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells

    Immunity, vol. 51, 2019, pp. 573-589.e8

  129. W. Fan, W. Zhang, S. Alshehri, T. R. Neeley, J. C. Garrison. Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor

    Eur J Med Chem, vol. 177, 2019, pp. 386-400

  130. Q. Fu, A. Piai, W. Chen, K. Xia, J. J. Chou. Structure determination protocol for transmembrane domain oligomers

    Nat Protoc, vol. 14, 2019, pp. 2483-2520

  131. J. Garousi, S. Lindbo, J. Borin, E. von Witting, A. Vorobyeva, M. Oroujeni, B. Mitran, A. Orlova, J. Buijs, V. Tolmachev, S. Hober. Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

    Eur J Pharm Biopharm, vol. 134, 2019, pp. 37-48

  132. K. E. Henry, M. M. Dacek, T. R. Dilling, J. D. Caen, I. L. Fox, M. J. Evans, J. S. Lewis. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

    Clin Cancer Res, vol. 25, 2019, pp. 166-176

  133. S. Heskamp, P. J. Wierstra, J. D. M. Molkenboer-Kuenen, G. W. Sandker, S. Thordardottir, J. Cany, D. Olive, J. Bussink, O. C. Boerman, H. Dolstra, Ehjg Aarntzen, W. A. Hobo. PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

    Cancer Immunol Res, vol. 7, 2019, pp. 150-161

  134. S. H. L. Hoffmann, D. I. Reck, A. Maurer, B. Fehrenbacher, J. E. Sceneay, M. Poxleitner, H. H. Öz, W. Ehrlichmann, G. Reischl, K. Fuchs, M. Schaller, D. Hartl, M. Kneilling, A. Möller, B. J. Pichler, C. M. Griessinger. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer

    Theranostics, vol. 9, 2019, pp. 5869-5885

  135. S. Imlimthan, S. Otaru, O. Keinänen, A. Correia, K. Lintinen, H. A. Santos, A. J. Airaksinen, M. A. Kostiainen, M. Sarparanta. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications

    Biomacromolecules, vol. 20, 2019, pp. 674-683

  136. N. Jailkhani, J. R. Ingram, M. Rashidian, S. Rickelt, C. Tian, H. Mak, Z. Jiang, H. L. Ploegh, R. O. Hynes. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix

    Proc Natl Acad Sci U S A, vol. 116, 2019, pp. 14181-14190

  137. L. K. Kristensen, C. Christensen, M. M. Jensen, B. J. Agnew, C. Schjöth-Frydendahl, A. Kjaer, C. H. Nielsen. Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model

    Theranostics, vol. 9, 2019, pp. 4409-4420

  138. L. K. Kristensen, C. Fröhlich, C. Christensen, M. C. Melander, T. T. Poulsen, G. R. Galler, J. Lantto, I. D. Horak, M. Kragh, C. H. Nielsen, A. Kjaer. CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

    Theranostics, vol. 9, 2019, pp. 8221-8238

  139. R. Ladjohounlou, C. Lozza, A. Pichard, J. Constanzo, J. Karam, P. Le Fur, E. Deshayes, V. Boudousq, S. Paillas, M. Busson, M. Le Blay, M. Jarlier, S. Marcatili, M. Bardiès, F. Bruchertseifer, A. Morgenstern, J. Torgue, I. Navarro-Teulon, J. P. Pouget. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy

    Clin Cancer Res, vol. 25, 2019, pp. 4775-4790

  140. H. J. Lee, E. B. Ehlerding, D. Jiang, T. E. Barnhart, T. Cao, W. Wei, C. A. Ferreira, P. Huang, J. W. Engle, W. Cai. Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection

    Am J Cancer Res, vol. 9, 2019, pp. 1454-1468

  141. W. G. Lesniak, C. Chu, A. Jablonska, B. Behnam Azad, O. Zwaenepoel, M. Zawadzki, A. Lisok, M. G. Pomper, P. Walczak, J. Gettemans, M. Janowski. PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration

    Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 1940-1951

  142. W. G. Lesniak, C. Chu, A. Jablonska, Y. Du, M. G. Pomper, P. Walczak, M. Janowski. A Distinct Advantage to Intraarterial Delivery of (89)Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier

    J Nucl Med, vol. 60, 2019, pp. 617-622

  143. M. Li, D. Jiang, T. E. Barnhart, T. Cao, J. W. Engle, W. Chen, W. Cai. Immuno-PET imaging of VEGFR-2 expression in prostate cancer with (89)Zr-labeled ramucirumab

    Am J Cancer Res, vol. 9, 2019, pp. 2037-2046

  144. Y. Liang, Q. Liu, Y. Zhou, S. Chen, L. Yang, M. Zhu, Q. Wang. Counting and Recognizing Single Bacterial Cells by a Lanthanide-Encoding Inductively Coupled Plasma Mass Spectrometric Approach

    Anal Chem, vol. 91, 2019, pp. 8341-8349

  145. A. Y. Liu, A. D. Kanan, T. P. Radon, S. Shah, M. E. Weeks, J. M. Foster, J. K. Sosabowski, L. Dumartin, T. Crnogorac-Jurcevic. AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

    Oncotarget, vol. 10, 2019, pp. 4276-4289

  146. Q. Liu, E. M. Johnson, R. K. Lam, Q. Wang, H. Bo Ye, E. N. Wilson, P. S. Minhas, L. Liu, M. S. Swarovski, S. Tran, J. Wang, S. S. Mehta, X. Yang, J. D. Rabinowitz, S. S. Yang, M. Shamloo, C. Mueller, M. L. James, K. I. Andreasson. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

    Nat Immunol, vol. 20, 2019, pp. 1023-1034

  147. Y. Liu, H. P. Luehmann, L. Detering, E. D. Pressly, A. J. McGrath, D. Sultan, A. Nguyen, S. Grathwohl, M. Shokeen, M. Zayed, R. J. Gropler, D. Abendschein, C. J. Hawker, P. K. Woodard. Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation

    ACS Appl Mater Interfaces, vol. 11, 2019, pp. 15316-15321

  148. C. Lohrmann, E. M. O'Reilly, J. A. O'Donoghue, N. Pandit-Taskar, J. A. Carrasquillo, S. K. Lyashchenko, S. Ruan, R. Teng, W. Scholz, P. W. Maffuid, J. S. Lewis, W. A. Weber. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

    Clin Cancer Res, vol. 25, 2019, pp. 7014-7023

  149. X. K. Lun, D. Szklarczyk, A. Gabor, N. Dobberstein, V. R. T. Zanotelli, J. Saez-Rodriguez, C. von Mering, B. Bodenmiller. Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling

    Mol Cell, vol. 74, 2019, pp. 1086-1102.e5

  150. S. Lütje, S. Heskamp, G. M. Franssen, C. Frielink, A. Kip, M. Hekman, G. Fracasso, M. Colombatti, K. Herrmann, O. C. Boerman, M. Gotthardt, M. Rijpkema. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

    Theranostics, vol. 9, 2019, pp. 2924-2938

  151. A. F. Maaland, H. Heyerdahl, A. O'Shea, B. Eiriksdottir, V. Pascal, J. T. Andersen, A. Kolstad, J. Dahle. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003

    Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 2311-2321

  152. O. A. Marcos-Contreras, J. S. Brenner, R. Y. Kiseleva, V. Zuluaga-Ramirez, C. F. Greineder, C. H. Villa, E. D. Hood, J. W. Myerson, S. Muro, Y. Persidsky, V. R. Muzykantov. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain

    J Control Release, vol. 301, 2019, pp. 54-61

  153. H. Mukai, K. Hatanaka, N. Yagi, S. Warashina, M. Zouda, M. Takahashi, K. Narushima, H. Yabuuchi, J. Iwano, T. Kuboyama, J. Enokizono, Y. Wada, Y. Watanabe. Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis

    J Control Release, vol. 294, 2019, pp. 185-194

  154. A. Natarajan, C. B. Patel, S. Ramakrishnan, P. S. Panesar, S. R. Long, S. S. Gambhir. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues

    Clin Cancer Res, vol. 25, 2019, pp. 1774-1785

  155. A. C. L. Opina, M. Strickland, Y. S. Lee, N. Tjandra, R. E. Swenson, O. Vasalatiy. Comparison of Solution Properties of Polymethylated DOTA-like Lanthanide Complexes with Opposite Chirality of the Pendant Arms

    Inorg Chem, vol. 58, 2019, pp. 15788-15800

  156. L. Pan, T. M. Fu, W. Zhao, L. Zhao, W. Chen, C. Qiu, W. Liu, Z. Liu, A. Piai, Q. Fu, S. Chen, H. Wu, J. J. Chou. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling

    Cell, vol. 176, 2019, pp. 1477-1489.e14

  157. D. N. Pandya, N. B. Bhatt, F. Almaguel, S. Rideout-Danner, H. D. Gage, K. K. Solingapuram Sai, T. J. Wadas. (89)Zr-Chloride Can Be Used for Immuno-PET Radiochemistry Without Loss of Antigen Reactivity In Vivo

    J Nucl Med, vol. 60, 2019, pp. 696-701

  158. H. H. Pang, P. Y. Chen, K. C. Wei, C. W. Huang, Y. L. Shiue, C. Y. Huang, H. W. Yang. Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors

    Theranostics, vol. 9, 2019, pp. 1752-1763

  159. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, L. M. Carter, Jacm Goos, Y. Y. Janjigian, J. S. Lewis. Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

    J Nucl Med, vol. 60, 2019, pp. 1569-1578

  160. J. Riegler, H. Gill, A. Ogasawara, M. Hedehus, V. Javinal, J. Oeh, G. Z. Ferl, J. Marik, S. Williams, D. Sampath, J. Schartner, R. A. D. Carano. VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models

    Neoplasia, vol. 21, 2019, pp. 1036-1050

  161. D. R. Roberts, A. R. Chatterjee. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body

    Invest Radiol, vol. 54, 2019, pp. 72-75

  162. E. Sanabria Español, M. Maldonado. Host-Guest Recognition of Pesticides by Calixarenes

    Crit Rev Anal Chem, vol. 49, 2019, pp. 383-394

  163. N. Schaduangrat, V. Prachayasittikul, S. Choomwattana, P. Wongchitrat, K. Phopin, W. Suwanjang, A. A. Malik, B. Vincent, C. Nantasenamat. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

    Med Res Rev, vol. 39, 2019, pp. 1730-1778

  164. I. H. Song, M. S. Jeong, H. J. Hong, J. I. Shin, Y. S. Park, S. K. Woo, B. S. Moon, K. I. Kim, Y. J. Lee, J. H. Kang, T. S. Lee. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model

    Clin Cancer Res, vol. 25, 2019, pp. 6148-6159

  165. S. M. Srideshikan, J. Brooks, D. Zuro, B. Kumar, J. Sanchez, L. Echavarria Parra, M. Orellana, P. Vishwasrao, I. Nair, J. Chea, K. Poku, N. Bowles, A. Miller, T. Ebner, J. Molnar, J. Rosenthal, D. A. Vallera, J. Y. C. Wong, A. S. Stein, D. Colcher, J. E. Shively, P. J. Yazaki, S. K. Hui. ImmunoPET, [(64)Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

    Clin Cancer Res, vol. 25, 2019, pp. 7463-7474

  166. T. A. R. Stallons, A. Saidi, I. Tworowska, E. S. Delpassand, J. J. Torgue, A. H. Staudacher, V. Liapis, W. Tieu, N. L. Wittwer, M. P. Brown. Preclinical Investigation of ²¹²Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model

    Mol Cancer Ther, vol. 18, 2019, pp. 1012-1021

  167. B. W. Stein, A. Morgenstern, E. R. Batista, E. R. Birnbaum, S. E. Bone, S. K. Cary, M. G. Ferrier, K. D. John, J. L. Pacheco, S. A. Kozimor, V. Mocko, B. L. Scott, P. Yang. Advancing Chelation Chemistry for Actinium and Other +3 f-Elements, Am, Cm, and La

    J Am Chem Soc, vol. 141, 2019, pp. 19404-19414

  168. H. Sudo, A. B. Tsuji, A. Sugyo, T. Saga, M. K. Kaneko, Y. Kato, T. Higashi. Therapeutic efficacy evaluation of radioimmunotherapy with (90) Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma

    Cancer Sci, vol. 110, 2019, pp. 1653-1664

  169. D. L. J. Thorek, A. T. Ku, N. Mitsiades, D. Veach, P. A. Watson, D. Metha, S. E. Strand, S. K. Sharma, J. S. Lewis, D. S. Abou, H. G. Lilja, S. M. Larson, M. R. McDevitt, D. Ulmert. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer

    Clin Cancer Res, vol. 25, 2019, pp. 881-891

  170. O. V. Timmermand, J. Elgqvist, K. A. Beattie, A. Örbom, E. Larsson, S. E. Eriksson, D. L. J. Thorek, B. J. Beattie, T. A. Tran, D. Ulmert, S. E. Strand. Preclinical efficacy of hK2 targeted [¹⁷⁷Lu]hu11B6 for prostate cancer theranostics

    Theranostics, vol. 9, 2019, pp. 2129-2142

  171. J. Wagner, M. A. Rapsomaniki, S. Chevrier, T. Anzeneder, C. Langwieder, A. Dykgers, M. Rees, A. Ramaswamy, S. Muenst, S. D. Soysal, A. Jacobs, J. Windhager, K. Silina, M. van den Broek, K. J. Dedes, M. Rodríguez Martínez, W. P. Weber, B. Bodenmiller. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer

    Cell, vol. 177, 2019, pp. 1330-1345.e18

  172. W. Wei, D. Jiang, Z. T. Rosenkrans, T. E. Barnhart, J. W. Engle, Q. Luo, W. Cai. HER2-targeted multimodal imaging of anaplastic thyroid cancer

    Am J Cancer Res, vol. 9, 2019, pp. 2413-2427

  173. S. K. Woo, S. J. Jang, M. J. Seo, J. H. Park, B. S. Kim, E. J. Kim, Y. J. Lee, T. S. Lee, G. I. An, I. H. Song, Y. Seo, K. I. Kim, J. H. Kang. Development of (64)Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies

    J Nucl Med, vol. 60, 2019, pp. 26-33

  174. X. Xie, Y. Chen, Z. Chen, Y. Feng, J. Wang, T. Li, S. Li, X. Qin, C. Wu, C. Zheng, J. Zhu, F. You, Y. Liu, H. Yang. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging

    ACS Appl Mater Interfaces, vol. 11, 2019, pp. 43865-43878

  175. C. Xu, J. Nam, H. Hong, Y. Xu, J. J. Moon. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy

    ACS Nano, vol. 13, 2019, pp. 12148-12161

  176. H. Yakushiji, K. Kobayashi, F. Takenaka, Y. Kishi, M. Shinohara, M. Akehi, T. Sasaki, E. Ohno, E. Matsuura. Novel single-chain variant of antibody against mesothelin established by phage library

    Cancer Sci, vol. 110, 2019, pp. 2722-2733

  177. Z. Yang, Y. Dai, L. Shan, Z. Shen, Z. Wang, B. C. Yung, O. Jacobson, Y. Liu, W. Tang, S. Wang, L. Lin, G. Niu, P. Huang, X. Chen. Tumour microenvironment-responsive semiconducting polymer-based self-assembly nanotheranostics

    Nanoscale Horiz, vol. 4, 2019, pp. 426-433

  178. 2018

  179. I. S. Alam, A. T. Mayer, I. Sagiv-Barfi, K. Wang, O. Vermesh, D. K. Czerwinski, E. M. Johnson, M. L. James, R. Levy, S. S. Gambhir. Imaging activated T cells predicts response to cancer vaccines

    J Clin Invest, vol. 128, 2018, pp. 2569-2580

  180. M. E. Autenrieth, C. Seidl, F. Bruchertseifer, T. Horn, F. Kurtz, B. Feuerecker, C. D'Alessandria, C. Pfob, S. Nekolla, C. Apostolidis, S. Mirzadeh, J. E. Gschwend, M. Schwaiger, K. Scheidhauer, A. Morgenstern. Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study

    Eur J Nucl Med Mol Imaging, vol. 45, 2018, pp. 1364-1371

  181. S. R. Banerjee, X. Song, X. Yang, I. Minn, A. Lisok, Y. Chen, A. Bui, S. Chatterjee, J. Chen, P. C. M. van Zijl, M. T. McMahon, M. G. Pomper. Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer

    Chemistry, vol. 24, 2018, pp. 7235-7242

  182. I. J. G. Burvenich, S. Parakh, F. T. Lee, N. Guo, Z. Liu, H. K. Gan, A. Rigopoulos, G. J. O'Keefe, S. J. Gong, Y. W. Goh, H. Tochon-Danguy, F. E. Scott, M. Kotsuma, K. Hirotani, G. Senaldi, A. M. Scott. Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a

    Theranostics, vol. 8, 2018, pp. 4199-4209

  183. M. N. Centelles, M. Wright, P. W. So, M. Amrahli, X. Y. Xu, J. Stebbing, A. D. Miller, W. Gedroyc, M. Thanou. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours

    J Control Release, vol. 280, 2018, pp. 87-98

  184. R. Chekol, V. R. Solomon, E. Alizadeh, W. Bernhard, D. Fisher, W. Hill, K. Barreto, J. F. DeCoteau, A. C. Parada, C. R. Geyer, H. Fonge. (89)Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

    Oncotarget, vol. 9, 2018, pp. 17117-17132

  185. W. Chen, J. Dev, J. Mezhyrova, L. Pan, A. Piai, J. J. Chou. The Unusual Transmembrane Partition of the Hexameric Channel of the Hepatitis C Virus

    Structure, vol. 26, 2018, pp. 627-634.e4

  186. C. C. Cheng, K. F. Chou, C. W. Wu, N. W. Su, C. L. Peng, Y. W. Su, J. Chang, A. S. Ho, H. C. Lin, C. G. Chen, B. L. Yang, Y. C. Chang, Y. W. Chiang, K. H. Lim, Y. F. Chang. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

    Lung Cancer, vol. 116, 2018, pp. 80-89

  187. S. Chevrier, H. L. Crowell, V. R. T. Zanotelli, S. Engler, M. D. Robinson, B. Bodenmiller. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry

    Cell Syst, vol. 6, 2018, pp. 612-620.e5

  188. E. Deshayes, R. Ladjohounlou, P. Le Fur, A. Pichard, C. Lozza, V. Boudousq, S. Sevestre, M. Jarlier, R. Kashani, J. Koch, J. Sosabowski, J. Foster, N. Chouin, F. Bruchertseifer, A. Morgenstern, P. O. Kotzki, I. Navarro-Teulon, J. P. Pouget. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer

    J Nucl Med, vol. 59, 2018, pp. 1234-1242

  189. X. Dong, W. Yin, X. Zhang, S. Zhu, X. He, J. Yu, J. Xie, Z. Guo, L. Yan, X. Liu, Q. Wang, Z. Gu, Y. Zhao. Intelligent MoS(2) Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging

    ACS Appl Mater Interfaces, vol. 10, 2018, pp. 4271-4284

  190. D. Duan, H. Liu, Y. Xu, Y. Han, M. Xu, Z. Zhang, Z. Liu. Activating TiO(2) Nanoparticles: Gallium-68 Serves as a High-Yield Photon Emitter for Cerenkov-Induced Photodynamic Therapy

    ACS Appl Mater Interfaces, vol. 10, 2018, pp. 5278-5286

  191. H. M. Gibson, B. N. McKnight, A. Malysa, G. Dyson, W. N. Wiesend, C. E. McCarthy, J. Reyes, W. Z. Wei, N. T. Viola-Villegas. IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy

    Cancer Res, vol. 78, 2018, pp. 5706-5717

  192. G. Han, M. H. Spitzer, S. C. Bendall, W. J. Fantl, G. P. Nolan. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry

    Nat Protoc, vol. 13, 2018, pp. 2121-2148

  193. M. C. Hekman, M. Rijpkema, C. H. Muselaers, E. Oosterwijk, C. A. Hulsbergen-Van de Kaa, O. C. Boerman, W. J. Oyen, J. F. Langenhuijsen, P. F. Mulders. Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study

    Theranostics, vol. 8, 2018, pp. 2161-2170

  194. L. Henderson, O. Neumann, C. Kaffes, R. Zhang, V. Marangoni, M. K. Ravoori, V. Kundra, J. Bankson, P. Nordlander, N. J. Halas. Routes to Potentially Safer T(1) Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence

    ACS Nano, vol. 12, 2018, pp. 8214-8223

  195. K. E. Henry, T. R. Dilling, D. Abdel-Atti, K. J. Edwards, M. J. Evans, J. S. Lewis. Noninvasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared with (18)F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer

    J Nucl Med, vol. 59, 2018, pp. 51-57

  196. A. I. Jensen, G. W. Severin, A. E. Hansen, F. P. Fliedner, R. Eliasen, L. Parhamifar, A. Kjær, T. L. Andresen, J. R. Henriksen. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of (52)Mn-DOTA and (64)Cu-DOTA using radiolabelled liposomes and PET imaging

    J Control Release, vol. 269, 2018, pp. 100-109

  197. S. K. Jones, K. Douglas, A. F. Shields, O. M. Merkel. Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model

    Biomaterials, vol. 178, 2018, pp. 183-192

  198. G. Kılıç, B. Osman, N. Tüzmen. Application of affinity microspheres for effective SPE cleanup before the determination of sulfamerazine by HPLC

    Mater Sci Eng C Mater Biol Appl, vol. 91, 2018, pp. 55-63

  199. H. Y. Kim, R. Li, T. S. C. Ng, G. Courties, C. B. Rodell, M. Prytyskach, R. H. Kohler, M. J. Pittet, M. Nahrendorf, R. Weissleder, M. A. Miller. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using (64)Cu-Labeled Macrin

    ACS Nano, vol. 12, 2018, pp. 12015-12029

  200. J. Lai, D. Lu, C. Zhang, H. Zhu, L. Gao, Y. Wang, R. Bao, Y. Zhao, B. Jia, F. Wang, Z. Yang, Z. Liu. Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy

    Biomaterials, vol. 158, 2018, pp. 1-9

  201. H. Lajous, R. Riva, B. Lelièvre, C. Tétaud, S. Avril, F. Hindré, F. Boury, C. Jérôme, P. Lecomte, E. Garcion. Hybrid Gd(3+)/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines

    Biomater Sci, vol. 6, 2018, pp. 2386-2409

  202. Y. Li, Y. Du, X. Liang, T. Sun, H. Xue, J. Tian, Z. Jin. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer

    Nanoscale, vol. 10, 2018, pp. 16738-16749

  203. N. Licciardello, S. Hunoldt, R. Bergmann, G. Singh, C. Mamat, A. Faramus, J. L. Z. Ddungu, S. Silvestrini, M. Maggini, L. De Cola, H. Stephan. Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor mice

    Nanoscale, vol. 10, 2018, pp. 9880-9891

  204. L. Liu, Q. Chen, C. Ruan, X. Chen, Y. Zhang, X. He, Y. Zhang, Y. Lu, Q. Guo, T. Sun, H. Wang, C. Jiang. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity

    Theranostics, vol. 8, 2018, pp. 2974-2987

  205. Y. Luo, E. H. Kim, C. A. Flask, H. A. Clark. Nanosensors for the Chemical Imaging of Acetylcholine Using Magnetic Resonance Imaging

    ACS Nano, vol. 12, 2018, pp. 5761-5773

  206. D. Mandikian, H. Rafidi, P. Adhikari, P. Venkatraman, L. Nazarova, G. Fung, I. Figueroa, G. Z. Ferl, S. Ulufatu, J. Ho, C. McCaughey, J. Lau, S. F. Yu, S. Prabhu, J. Sadowsky, C. A. Boswell. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging

    MAbs, vol. 10, 2018, pp. 1269-1280

  207. C. D. Martins, C. Da Pieve, T. A. Burley, R. Smith, D. M. Ciobota, L. Allott, K. J. Harrington, W. J. G. Oyen, G. Smith, G. Kramer-Marek. HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging

    Clin Cancer Res, vol. 24, 2018, pp. 1853-1865

  208. K. E. Mayer, S. Mall, N. Yusufi, D. Gosmann, K. Steiger, L. Russelli, H. O. Bianchi, S. Audehm, R. Wagner, E. Bräunlein, A. Stelzl, F. Bassermann, W. Weichert, W. Weber, M. Schwaiger, C. D\'Alessandria, A. M. Krackhardt. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target

    Theranostics, vol. 8, 2018, pp. 6070-6087

  209. V. R. N, H. S. Han, H. Lee, V. Q. Nguyen, S. Jeon, D. W. Jung, J. Lee, G. R. Yi, J. H. Park. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy

    Nanoscale, vol. 10, 2018, pp. 9616-9627

  210. E. Pérez, K. Bierla, G. Grindlay, J. Szpunar, J. Mora, R. Lobinski. Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry

    Anal Chim Acta, vol. 1018, 2018, pp. 7-15

  211. A. S. Pitek, H. Hu, S. Shukla, N. F. Steinmetz. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles

    ACS Appl Mater Interfaces, vol. 10, 2018, pp. 39468-39477

  212. E. C. Pratt, T. M. Shaffer, Q. Zhang, C. M. Drain, J. Grimm. Nanoparticles as multimodal photon transducers of ionizing radiation

    Nat Nanotechnol, vol. 13, 2018, pp. 418-426

  213. M. Rabyk, A. Galisova, M. Jiratova, V. Patsula, L. Srbova, L. Loukotova, J. Parnica, D. Jirak, P. Stepanek, M. Hruby. Mannan-based conjugates as a multimodal imaging platform for lymph nodes

    J Mater Chem B, vol. 6, 2018, pp. 2584-2596

  214. F. Romero Pastrana, J. M. Thompson, M. Heuker, H. Hoekstra, C. A. Dillen, R. V. Ortines, A. G. Ashbaugh, J. E. Pickett, M. D. Linssen, N. M. Bernthal, K. P. Francis, G. Buist, M. van Oosten, G. M. van Dam, D. L. J. Thorek, L. S. Miller, J. M. van Dijl. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe

    Virulence, vol. 9, 2018, pp. 262-272

  215. T. H. Shin, S. Kang, S. Park, J. S. Choi, P. K. Kim, J. Cheon. A magnetic resonance tuning sensor for the MRI detection of biological targets

    Nat Protoc, vol. 13, 2018, pp. 2664-2684

  216. G. Sun, Y. Zhang, Y. Zhang, Z. Hu, Z. Xing, S. Zhang, X. Zhang. Ratiometric quantification of β2-microglobulin antigen in human serum based on elemental labeling strategy

    Talanta, vol. 189, 2018, pp. 249-253

  217. W. K. Tsai, K. A. Zettlitz, R. Tavaré, N. Kobayashi, R. E. Reiter, A. M. Wu. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody

    Theranostics, vol. 8, 2018, pp. 5903-5914

  218. G. A. Ulaner, S. K. Lyashchenko, C. Riedl, S. Ruan, P. B. Zanzonico, D. Lake, K. Jhaveri, B. Zeglis, J. S. Lewis, J. A. O'Donoghue. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using (89)Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

    J Nucl Med, vol. 59, 2018, pp. 900-906

  219. T. van der Geest, D. M. Roeleveld, B. Walgreen, M. M. Helsen, T. K. Nayak, C. Klein, M. Hegen, G. Storm, J. M. Metselaar, W. B. van den Berg, P. M. van der Kraan, P. Laverman, O. C. Boerman, M. I. Koenders. Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis

    Rheumatology (Oxford), vol. 57, 2018, pp. 737-747

  220. H. Yamada, M. Yamashita, H. Hayashi, M. Suzuki, N. Aratani. Semiconducting π-Extended Tetrathiafulvalene Derivatives

    Chemistry, vol. 24, 2018, pp. 18601-18612

  221. H. Yan, X. Gao, Y. Zhang, W. Chang, J. Li, X. Li, Q. Du, C. Li. Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe

    ACS Appl Mater Interfaces, vol. 10, 2018, pp. 17047-17057

  222. Q. Yin, L. Tang, K. Cai, X. Yang, L. Yin, Y. Zhang, L. W. Dobrucki, W. G. Helferich, T. M. Fan, J. Cheng. Albumin as a Trojan Horse for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting

    Biomater Sci, vol. 6, 2018, pp. 1189-1200

  223. J. T. Yoon, M. S. Longtine, B. V. Marquez-Nostra, R. L. Wahl. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with (89)Zr in Human Lymphoma Xenografts

    J Nucl Med, vol. 59, 2018, pp. 1219-1224

  224. Y. Yoshii, M. Yoshimoto, H. Matsumoto, H. Tashima, Y. Iwao, H. Takuwa, E. Yoshida, H. Wakizaka, T. Yamaya, M. R. Zhang, A. Sugyo, S. Hanadate, A. B. Tsuji, T. Higashi. Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with (64)Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts

    Oncotarget, vol. 9, 2018, pp. 28935-28950

  225. Y. Zhang, G. Sun, Y. Zhang, B. Huang, Z. Xing, S. Zhang, X. Zhang. Simultaneous competitive and sandwich formats multiplexed immunoassays based on ICP-MS detection

    Talanta, vol. 185, 2018, pp. 237-242

  226. 2014

  227. A. G. Terwisscha van Scheltinga, P. Berghuis, H. H. Nienhuis, H. Timmer-Bosscha, L. Pot, S. B. Gaykema, M. N. Lub-de Hooge, J. G. Kosterink, E. G. de Vries, C. P. Schröder. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer

    Eur J Cancer, vol. 50, 2014, pp. 2508-16

  228. 2011

  229. W. B. Nagengast, M. N. Hooge, E. M. van Straten, S. Kruijff, A. H. Brouwers, W. F. den Dunnen, J. R. de Jong, H. Hollema, R. A. Dierckx, N. H. Mulder, E. G. de Vries, H. J. Hoekstra, G. A. Hospers. VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients

    Eur J Cancer, vol. 47, 2011, pp. 1595-602